Efficacy, Safety and Predictive Factors for Outcomes and Adverse Events in Sclerotherapy for Venous Malformations in Children

In brief

This study evaluates polidocanol sclerotherapy outcomes in pediatric patients with venous malformations, addressing a gap in pediatric-specific data. The research examines treatment efficacy, safety profiles, and identifies predictive factors for both successful outcomes and adverse events in this young population.

• Percutaneous sclerotherapy is an established treatment for venous malformations but pediatric data remain limited.
• This study evaluates polidocanol-based sclerotherapy efficacy and safety specifically in children with venous malformations.
• The research identifies predictive factors for both clinical outcomes and adverse events in pediatric sclerotherapy patients.
• Polidocanol is the sclerosing agent of choice, requiring outcome data to optimize pediatric treatment protocols.

Written by the GCMD Library team from the article.